Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2010 | 07-2010 | 04-2010 | 01-2010 | 10-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -645 | -591 | -2,923 | -2,371 | -1,587 |
| Depreciation Amortization | 20 | 10 | 32 | 24 | 16 |
| Accounts receivable | -289 | 13 | -46 | -414 | N/A |
| Accounts payable and accrued liabilities | 438 | 165 | -471 | -528 | -229 |
| Other Working Capital | -928 | -25 | 1 | -1,279 | -920 |
| Other Operating Activity | 218 | -8 | 1,307 | 1,460 | 588 |
| Operating Cash Flow | $-1,186 | $-436 | $-2,100 | $-3,108 | $-2,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,017 | 1,017 | 1,017 |
| PPE Investments | -25 | -20 | -76 | -40 | -32 |
| Investing Cash Flow | $-25 | $-20 | $941 | $977 | $985 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | 2,225 | 2,078 | 3 |
| Common Stock Repurchased | -73 | -31 | -218 | -188 | -188 |
| Financing Cash Flow | $-73 | $-31 | $2,007 | $1,890 | $-185 |
| Exchange Rate Effect | -25 | 3 | -4 | -8 | -2 |
| Beginning Cash Position | 2,572 | 2,572 | 1,728 | 1,728 | 1,728 |
| End Cash Position | 1,263 | 2,088 | 2,572 | 1,479 | 394 |
| Net Cash Flow | $-1,309 | $-484 | $844 | $-249 | $-1,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,186 | -436 | -2,100 | -3,108 | -2,132 |
| Capital Expenditure | -25 | -20 | -84 | -40 | -32 |
| Free Cash Flow | -1,211 | -456 | -2,184 | -3,148 | -2,164 |